# Dolutegravir and Clinical Outcomes Among ART-recipients in Brazil

> **NCT04326504** · — · UNKNOWN · sponsor: **Fundação Bahiana de Infectologia** · enrollment: 5000 (estimated)

## Conditions studied

- HIV Infections
- Clinical Outcomes
- Adverse Drug Event
- Effect of Drugs

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT04326504
- **Lead sponsor:** Fundação Bahiana de Infectologia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-02-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-02-28
- **Target enrollment:** 5000 (ESTIMATED)
- **Last updated:** 2024-02-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04326504

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04326504, "Dolutegravir and Clinical Outcomes Among ART-recipients in Brazil". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04326504. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*